has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic review of the division.
Nestle said it has offloaded Palforzia to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of allergies.Reporting by John Revill, Editing by Friederike Heine
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: Investingcom - 🏆 450. / 53 続きを読む »
ソース: Cointelegraph - 🏆 562. / 51 続きを読む »